
|Videos|March 31, 2022
AMCP 2022: Katie Lockhart of Magellan Health Talks the Financial Impact of Specialty Drugs & Cost-Impact Models
Author(s)MHE Staff
Katie Lockhart, MA, manager of Magellan Health, addresses her AMCP 2022 conference session on the financial impact of specialty drugs and cost-impact models.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Researchers discover new pathway to fight liver inflammation
2
FDA approves $2.7 million gene therapy for rare metabolic disorder
3
Overlooked bladder nerves now thought to reduce UTI burden through pain signaling, study shows
4
HIV medication adherence follows SNAP payment timing, study finds
5






















